Deerfield Management Company »

Bio-Rad Laboratories shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Bio-Rad Laboratories (BIO) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Bio-Rad Laboratories

Tip: Access up to 7 years of quarterly data

All positions including Bio-Rad Laboratories held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bio-Rad Laboratories by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $49M 152k 322.89
2023-09-30 $62M 174k 358.45

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Bio-Rad Laboratories

Vanguard Group
Veritas Asset Management
Ubs Global Asset Management Americas
Alliancebernstein
Investec Asset Management
Earnest Partners
Bank of America Corporation
Southeastern Asset Management
Thompson, Siegel, & Walmsley
Massachusetts Financial Services
Hound Partners
Westfield Capital Management Company
Parnassus Investments
Norges Bank Investment Management
Millennium Management

View all funds holding Bio-Rad Laboratories